RRA
FENC icon

Round Rock Advisors’s Fennec Pharmaceuticals FENC Stock Holding History

Round Rock Advisors’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$523K Buy
+48,683
New +$397K 0.07% 212

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Round Rock Advisors's FENC Position: Q2 2026 in Review

Round Rock Advisors opened a new position in Fennec Pharmaceuticals (FENC) in Q2 2026: 48,683 shares worth $523K. The stake represents 0.07% of the portfolio and ranks #212 among its holdings.

104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Round Rock Advisors held 48,683 shares of Fennec Pharmaceuticals worth $523K as of Q2 2026.
  • Fennec Pharmaceuticals was a new Round Rock Advisors position in Q2 2026.
  • Fennec Pharmaceuticals made up 0.07% of Round Rock Advisors's portfolio in Q2 2026, its #212 holding.
  • 104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Round Rock Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.